Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[RichDude]

Some points on CRXM. The phase 3 cardiovascular drug is about to go on the market, in Russia. The company is working on gene based drugs /therapy, and, this also has implications in the cancer area. As well, they are being asked to present all over the country.

In my opinion, this one is going to be a big gainer when the FDA approves the phase 3 drug for the U.S. And, big pharma reps are at all of the conferences where they are presenting. So, there are a lot of possibilities.

If you look under the investors section of their website, you will find a 78 page presentation. And, it is impressive. But, what I like the MOST about this stock is that it is *new* to iHub, and, very few people are talking about it on the web.

So, it is an unknown gene based stock trading in the .20 range. Most gene based drug stocks (like VBL Tee) are trading in the $4-7 range. And, a lot of them only have one drug. CRXM already has an FDA approved drug, one in phase 3, and, another in development!

It is WAY undervalued, if you ask me. : )